Contract award record
NHS National Pharmaceuticals Transition 2019_1 - Contracts Finder Award Notice
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer and contract winner
Public buyer
NHS Englandawarded to
Contract winner
Please see list of awarded suppliers (including SME status) at tAward value£28,656,720
- AwardedCompleted
- StartCompleted
- EndCompleted
Work description
NHS National Pharmaceuticals Transition 2019_1 Offer reference number: CM/PHG/17/5547 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 34 months Potential periods of call-offs under the framework agreement: LSNE: 01/10/2019 to 30/04/2020 (7 months) CESW: 01/10/2019 to 30/09/2020 (12 months) NWLN: 01/10/2019 to 28/02/2021 (17 months)
Awarded product list bortezomib, arsenic, darunavir, atazanavir, ritonavir, miglustat, gefitinib, carglumic acid, clofaribine, ganciclovir, aprepitant, dexmedetomidine, solifenacin, atomoxetine, atovaquone, metaraminol and olopatadine
Related awards
From this public buyer
View all awards from this public buyerFrom this contract winner
- NHS National Pharmaceuticals Transition 2020_2
£7,190,000 ·